October 2, 2014
Why is a payday loan right for you Payday loan 50 up to
Payday loans uk

Harm Reduction in Georgia

Posted on July 18, 2014 by in Features

The Price of Zero Drug Policies in Former Soviet Republics, Like Georgia, Are Spiking HIV and HCV Rates by Larry Buhl Georgia is facing the same problem as other Soviet republics: a surging rate of HIV and hepatitis C (HCV). Harm reduction advocates and NGOs have concluded that these surges have been exacerbated by government [...]

HCV & Underreporting

Posted on May 13, 2014 by in Hep Talk, LifeGuide

By the Numbers While HCV prevalence is down, the rate of morbidity may be going up by Larry Buhl New data on the prevalence of hepatitis C virus (HCV) in the U.S. shows that, with a “silent epidemic,” it’s hard to get accurate numbers. A disease that often has no symptoms, and that hits populations [...]

Coffee & HCV

Posted on March 6, 2014 by in Hep Talk, LifeGuide

Coffee Talk Two studies shed light on HCV prevention & treatment by Larry Buhl A study on the long-term infectiousness of the hepatitis C virus (HCV) has implications for healthcare workers, IV drug users, and tattoo artists, while another study shows the benefits of coffee and tea on liver inflammation in chronic hepatitis C patients. [...]

HCV Serosorting

Posted on January 24, 2014 by in Hep Talk, LifeGuide

Testing, Testing Serosorting is common for IV drug users who know their HCV status by Larry Buhl A new study shows IV drug users who know they carry the hepatitis C virus are likely to consider their serostatus when deciding whether and with whom to share injection equipment. The results, published in the December 15, [...]

Hep C & Adult Films

Posted on October 30, 2013 by in Hep Talk, LifeGuide

Hep Talk by Larry Buhl Hep X Does the porn industry have a hepatitis problem? Actors who work for legitimate adult entertainment producers, who are mostly based in Los Angeles, now have to submit to monthly tests for hepatitis B and C as well as for Trichomoniasis vaginalis, a sexually transmitted infection of the urogenital [...]

Man to Man

Posted on May 29, 2013 by in Hep Talk, LifeGuide

Hep Talk by Larry Buhl For MSMs: treatment hope for HCV—and a warning There’s more evidence of the effectiveness of new antiretroviral drugs in treating the hepatitis C virus (HCV). This time it’s a study, presented at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in March in Atlanta, that showed adding telaprevir [...]

Cure for Hep C

Posted on September 24, 2012 by in Columns, Left Field

Left Field by Patricia Nell Warren A new drug helps as many as eighty percent of those living with HCV So often, I have to report bad news about the greed, corruption and malfeasance that infests much of the biomedical world today. So for once I’m glad to report some good news—namely a cure that [...]

Blocking the Entrance

Posted on February 24, 2012 by in Hep Talk, LifeGuide

Entry inhibitors usher in a new phase of hep C research by Larry Buhl Future therapy for hepatitis C infection may include a variety of drugs working together to target the virus at multiple stages of its life cycle, according to a research team at the University of Illinois at Chicago College of Medicine, which [...]

Taking a Toll

Posted on February 4, 2012 by in Hep Talk, LifeGuide

LifeGuide [Hep Talk] Hep C is surpassing HIV as a deadlier disease by Larry Buhl There was a new milestone reached last month when a new study suggested that the number of deaths from chronic hepatitis C now exceed those from HIV-related illnesses. The study was released by the U.S. Centers for Disease Control and [...]

Red Flags

Posted on December 9, 2011 by in Hep Talk, LifeGuide, Noteworthy

LifeGuide [Hep Talk] African Americans face medical barriers to HCV treatment by Larry Buhl In the U.S. blacks are disproportionately infected with the hepatitis C virus (HCV), and are less likely to receive treatment for HCV than whites. Treatment barriers go beyond affordability and lack of access to care. A new study shows that, significantly, [...]